Pan-cancer analysis of the prognostic and immunological role of GJB2: a potential target for survival and immunotherapy

被引:10
|
作者
Jia, Yuting [1 ]
Guo, Bin [1 ]
Zhang, Wenbin [1 ]
Wang, Feng [1 ]
Zhang, Yong [1 ]
Zhang, Quanmao [1 ]
Li, Erfeng [1 ]
机构
[1] Shanxi Prov Canc Hosp, Dept Endoscopy Ctr, Taiyuan, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2023年 / 13卷
关键词
pan-cancer; prognosis; immune infiltration; TMB; MSI; ICP; CONNEXIN; 26; INTERCELLULAR COMMUNICATION; TUMOR MICROENVIRONMENT; EXPRESSION; BLOCKADE; NEOANTIGENS; PROGRESSION; METASTASIS; RELEASE; GROWTH;
D O I
10.3389/fonc.2023.1110207
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundGJB2 plays an essential role in the growth and progression of several cancers. However, asystematic pan-cancer analysis of GJB2 is lacking. Therefore, in this study, we performed a comprehensive pan-cancer analysis to determine the potential role of GJB2 in prognostic prediction and cancer immunotherapy response. MethodsThe differential expression of GJB2 in the tumor and adjacent normal tissues of various cancer types was analyzed using the TIMER, GEPIA, and Sangerbox databases. GEPIA and Kaplan-Meier plotter databases were used to analyze the survival outcomes based on GJB2 expression levels in pan-cancer. Furthermore, the association of GJB2 expression with the immune checkpoint (ICP) genes, tumor mutational load (TMB), microsatellite instability (MSI), neoantigens, and tumor infiltration of immune cells was analyzed using via the Sangerbox database. The cBioPortal database was used to determine the characteristics of GJB2 gene alterations in the cancer tissues. The STRING database was used to identify the GJB2-binding proteins. GEPIA database was used to identify the GJB2 co-expressed genes. DAVID was used to perform the functional enrichment analysis of gene ontology (GO) terms and KEGG pathways associated with GJB2. Finally, the mechanistic role of GJB2 in pancreatic adenocarcinoma (PAAD) was analyzed using the LinkedOmics database. ResultsThe GJB2 gene was highly expressed in a variety of tumors. Furthermore, GJB2 expression levels showed significant positive or negative association with the survival outcomes in various cancers. GJB2 expression levels cor related with tumor mutational burden, microsatellite instability, neoantigens, and tumor infiltration of immune cells in multiple cancers. This suggested that GJB2 played a critical role in the tumor microenvironment. Functional enrichment analysis showed that the biological role of GJB2 in tumors included modulation of gap junction-mediated intercellular transport, regulation of cell communication by electrical coupling, ion transmembrane transport, autocrine signaling, apoptotic signaling pathway, NOD-like receptor signaling pathway, p53 signaling pathway, and PI3K-Akt signaling pathway. ConclusionsOur study demonstrated that GJB2 played a significant role in tumorigenesis and tumor immunity in multiple cancers. Furthermore, GJB2 is a potential prognostic biomarker and a promising therapeutic target in multiple types of cancers.
引用
收藏
页数:20
相关论文
共 50 条
  • [31] Bioinformatics analysis of prognostic value and immunological role of MeCP2 in pan-cancer
    Yanfeng Wang
    Yunqing Zhang
    Fenghui Wang
    Ting Li
    Xinqiu Song
    Haiyan Shi
    Juan Du
    Huahua Zhang
    Hongmei Jing
    Jiaqi Han
    Dongdong Tong
    Jing Zhang
    Scientific Reports, 12
  • [32] Pan-cancer analysis reveals IGFL2 as a potential target for cancer prognosis and immunotherapy
    Yuqi Wang
    Hongwei Yuan
    Genquan Yue
    Lingyan Zhao
    Yuan Xia
    Nan Zhang
    Hailing Li
    Dongyang Liu
    Yubo Su
    Haisheng Wang
    Yumin Gao
    Scientific Reports, 13
  • [33] NEK2 is a potential pan-cancer biomarker and immunotherapy target
    Zhang, Lanyue
    Li, Yang
    Deng, Juexiao
    Liao, Wenxin
    Liu, Tingting
    Shen, Fujin
    DISCOVER ONCOLOGY, 2024, 15 (01)
  • [34] Pan-cancer analysis of the prognostic and immunological role of ANLN: An onco-immunological biomarker
    Liu, Kejun
    Cui, Lei
    Li, Cunquan
    Tang, Chaofeng
    Niu, Yiming
    Hao, Ji
    Bu, Yang
    Chen, Bendong
    FRONTIERS IN GENETICS, 2022, 13
  • [35] Pan-Cancer Analysis of the Oncogenic and Immunological Role of RCN3: A Potential Biomarker for Prognosis and Immunotherapy
    Ding, Jian
    Meng, Yan
    Han, Zelong
    Luo, Xiaobei
    Guo, Xuxue
    Li, Yiwen
    Liu, Side
    Zhuang, Kangmin
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [36] Pan-cancer analysis of ITGB3 as a potential prognostic and immunological biomarker
    Changshun Chen
    Lei Wen
    Ge Chen
    Fei Yang
    Zhong Chen
    Jianhua Ji
    Jinyi Gu
    Discover Oncology, 16 (1)
  • [37] Pan-cancer analysis of ABCC1 as a potential prognostic and immunological biomarker
    Wang, Tiantian
    Rao, Dean
    Fu, Chenan
    Luo, Yiming
    Lu, Junli
    Liang, Huifang
    Xia, Limin
    Huang, Wenjie
    TRANSLATIONAL ONCOLOGY, 2024, 41
  • [38] PRKCSH serves as a potential immunological and prognostic biomarker in pan-cancer
    Qiankun Wang
    Xiong Wang
    Jiaoyuan Li
    Tongxin Yin
    Yi Wang
    Liming Cheng
    Scientific Reports, 14
  • [39] PRKCSH serves as a potential immunological and prognostic biomarker in pan-cancer
    Wang, Qiankun
    Wang, Xiong
    Li, Jiaoyuan
    Yin, Tongxin
    Wang, Yi
    Cheng, Liming
    SCIENTIFIC REPORTS, 2024, 14 (01)
  • [40] Comprehensive prognostic and immunological analysis of CCT2 in pan-cancer
    Lv, Wenming
    Shi, Lin
    Pan, Jiebing
    Wang, Shengbao
    FRONTIERS IN ONCOLOGY, 2022, 12